OraSure Technologies to Hold Virtual Annual Meeting of Stockholders on May 21, 2019

OraSure Technologies, Inc. (NASDAQ: OSUR), announced that its 2019 Annual Meeting of Stockholders will be a completely virtual meeting, conducted as a live webcast beginning at 10:00 a.m. EDT (7:00 a.m. PDT) on Tuesday, May 21, 2019.

In order to access the meeting, a stockholder or a person holding a valid stockholder proxy may go to www.virtualshareholdermeeting.com/OSUR2019 five (5) minutes prior to the start of the meeting to log in.  A stockholder must enter the control number that was provided in the Notice Regarding the Availability of Proxy Materials, proxy card or other proxy materials received by such stockholder in order to vote and ask questions that are germane to the business being discussed at the meeting.

A replay of the webcast will be available 24 hours after the meeting is concluded and will be archived on OraSure Technologies' website for seven days.

About OraSure Technologies

OraSure Technologies is empowering the global community to improve health and wellness by providing access to accurate essential information.  OraSure is a leader in the development, manufacture and distribution of point-of-care diagnostic tests, molecular collection devices and other technologies designed to detect or diagnose critical medical conditions. Its first-to-market, innovative products include rapid tests for the detection of antibodies to HIV and Hepatitis C (HCV) on the OraQuick® platform, sample self-collection and stabilization products for molecular applications, and oral fluid laboratory tests for detecting various drugs of abuse. Together with its wholly-owned subsidiaries (DNA Genotek, CoreBiome and Novosanis), OraSure provides its customers with value-added, end-to-end solutions that encompass tools, diagnostics and services. OraSure’s portfolio of products is sold globally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, research institutions, distributors, government agencies, physicians’ offices, commercial and industrial entities and direct to consumers.

For more information on OraSure Technologies, please visit www.orasure.com.

Company Contact:

Roberto Cuca	Jeanne Mell
Chief Financial Officer	VP Corporate Communications
[phone]	[phone]
[e-mail]	[e-mail]
www.orasure.com	www.orasure.com